Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v12-FR | Version v11-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2022-07-12 | 2022-07-12 |
| Drug Identification Number | 02221314 | 02221314 |
| Brand name | HYMENOPTERA VENOM PRODUCT-MIXED VESPID VENOM PROTEIN (1650 MCG) | HYMENOPTERA VENOM PRODUCT-MIXED VESPID VENOM PROTEIN (1650 MCG) |
| Common or Proper name | Mixed Vespid Venom Protein | Mixed Vespid Venom Protein |
| Company Name | JUBILANT HOLLISTERSTIER LLC | JUBILANT HOLLISTERSTIER LLC |
| Ingredients | WHITE FACED HORNET VENOM PROTEIN YELLOW HORNET VENOM PROTEIN YELLOW JACKET VENOM PROTEIN | WHITE FACED HORNET VENOM PROTEIN YELLOW HORNET VENOM PROTEIN YELLOW JACKET VENOM PROTEIN |
| Strength(s) | 550MCG 550MCG 550MCG | 550MCG 550MCG 550MCG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS | SUBCUTANEOUS |
| Packaging size | 1650ug | 1650ug |
| ATC code | V01AA | V01AA |
| ATC description | ALLERGENS | ALLERGENS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-02-14 | 2020-02-14 |
| Actual start date | 2020-02-14 | 2020-02-14 |
| Estimated end date | 2022-06-01 | 2022-06-01 |
| Actual end date | 2022-06-01 | 2022-06-01 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | This notification relates to an interruption in manufacturing due to on-going mechanical issues associated with our commercial Small Lot Manufacturing (SLM) area lyophilizer. | This notification relates to an interruption in manufacturing due to on-going mechanical issues associated with our commercial Small Lot Manufacturing (SLM) area lyophilizer. |
| Health Canada comments |